UNSPSC 51433403: Quinapril

This classification denotes an ace inhibitor with the molecular formula C25H30N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RJ84Y44811, chemically known as 3-isoquinolinecarboxylic acid, 2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s-(2(r*(r*)),3r*))- but generally known as quinapril, which bears US NIH Compound Identifier 54892. European Medicines Agency schedules Quinapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10201MIG.

UNSPSC 51433403 Quinapril, a Commodity code, captures state and local procurement of specific pharmaceutical active ingredients and formulations for emergency medical services, institutional healthcare delivery, and pharmacy benefit programs. The code sees activity across fire rescue services, state health agencies, and multistate cooperative purchasing alliances buying branded and generic medications for operational inventory and benefit plan fulfillment. Recent solicitations span emergency life support medications for paramedics and EMTs, direct-to-manufacturer prescription fulfillment programs, and generic pharmaceuticals distributed through established wholesaler networks to state and local government facilities. Issuing bodies include city fire departments, state health and human services commissions managing pharmacy benefits for state employees and Medicaid populations, and cooperative purchasing organizations serving multiple state and local jurisdictions in concert.

The code shows recent activity concentrated in Florida and Texas, with a multistate cooperative purchasing component spanning Minnesota, Oregon, and participating member jurisdictions. Representative recent opportunities include the City of Tampa's sealed bid for Advanced Life Support Medications (IFB No. 26P00188, due April 8, 2026) to supply 370 units of Labetalol HCI, 1,810 units of Epinephrine, 330 units of Adenosine, and 1,020 units of Diltiazem for Tampa Fire Rescue at an estimated contract value of $40,000; the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription fulfillment capabilities (HHS0017013, issued April 3, 2026) to explore vendor capacity for self-insured pharmacy contracting outside traditional PBM and GPO channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) requiring NDC-specific product submissions through authorized wholesalers with contracts effective July 1, 2026. Vendors in active bids face requirements for expiration dating minimums, cGMP and Drug Supply Chain Security Act compliance, wholesaler channel partnerships, and OSHA Safety Data Sheet documentation.